Thu. 9 May 2024, 8:58am ET
Benzinga
Earnings, Earnings Misses, News
Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.51) by 13.73 percent. This is a 51.26 percent increase over losses of $(1.19) per share from the same period last year.